Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Briefings in Functional Genomics
|
December 25, 2010
Non-coding RNAs: could they be the answer?
Fabricio F Costa
Drug Discovery Today
|
October 30, 2012
Social networks, web-based tools and diseases: implications for biomedical research
Fabricio F Costa
Cancer Management and Research
|
December 29, 2010
Epigenomics in cancer management
Fabricio F Costa
Drug Discovery Today
|
November 5, 2013
Big data in biomedicine
Fabricio F Costa
Pharmacology & Therapeutics
|
March 24, 2015
Epigenomes as therapeutic targets
Christopher A Hamm, Fabricio F Costa
Drug Discovery Today
|
May 17, 2011
The impact of epigenomics on future drug design and new therapies
Christopher A Hamm, Fabricio F Costa
The Application of Clinical Genetics
|
June 19, 2013
DataGenno: building a new tool to bridge molecular and clinical genetics
Fabricio F Costa, Luciano S Foly, Marcelo P Coutinho
Pharmacology & Therapeutics
|
October 13, 2017
Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment
Michel L Leite, Nicolau B da Cunha, Fabricio F Costa
Drug Discovery Today
|
December 3, 2014
Splice variants in the proteome: a promising and challenging field to targeted drug discovery
Raphael Tavares, Nicole M Scherer, Carlos G Ferreira, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 27, 2009
Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter
Marzena A Lewandowska, Fabricio F Costa, Jared M Bischof, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Briefings in Functional Genomics
|
December 25, 2010
Non-coding RNAs: could they be the answer?
Fabricio F Costa
Drug Discovery Today
|
October 30, 2012
Social networks, web-based tools and diseases: implications for biomedical research
Fabricio F Costa
Cancer Management and Research
|
December 29, 2010
Epigenomics in cancer management
Fabricio F Costa
Drug Discovery Today
|
November 5, 2013
Big data in biomedicine
Fabricio F Costa
Pharmacology & Therapeutics
|
March 24, 2015
Epigenomes as therapeutic targets
Christopher A Hamm, Fabricio F Costa
Drug Discovery Today
|
May 17, 2011
The impact of epigenomics on future drug design and new therapies
Christopher A Hamm, Fabricio F Costa
The Application of Clinical Genetics
|
June 19, 2013
DataGenno: building a new tool to bridge molecular and clinical genetics
Fabricio F Costa, Luciano S Foly, Marcelo P Coutinho
Pharmacology & Therapeutics
|
October 13, 2017
Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment
Michel L Leite, Nicolau B da Cunha, Fabricio F Costa
Drug Discovery Today
|
December 3, 2014
Splice variants in the proteome: a promising and challenging field to targeted drug discovery
Raphael Tavares, Nicole M Scherer, Carlos G Ferreira, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 27, 2009
Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter
Marzena A Lewandowska, Fabricio F Costa, Jared M Bischof, et al.
Page
of 4